pain
Conditions
Interventions
0.1% Sufentanil Group:Intravenous infusion of 0.1% sufentanil 1 ml
0.02% Sufentanil Group:Intravenous infusion of 0.02% sufentanil 5 ml
0.01% Sufentanil Group:Intravenous infusion of 0.01% sufentanil 10 ml
Sponsors
The second affiliated hospital of Nantong university
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)Patients undergoing elective painless gastroscopy(2)18~65 years(3)No restrictions on gender(4)ASA I~II
Exclusion criteria
Exclusion criteria: (1)Patients with poor liver function or kidney function;(2)Patients with severe arrhythmia or cardiac insufficiency;(3)Patients who are allergic to propofo or sufentanil;(4)Patients who BMI>28kg/m2;(5)Patients with a preoperative assessment of difficult airway;(6)Patients who are suffering chronic pain or long-term taking analgesic drugs ;(7)Patients with intracranial and psychiatric disorders;(8)Patients who refuse to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical scoring of pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of respiratory depression and other complications;Recovery time;Total propofol dosage ; | — |
Countries
China
Contacts
Public Contactyaolei
The second affiliated hospital of Nantong university
Outcome results
None listed